We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Conjunctival Swab Real Time-PCR in Leishmania infantum Seropositive Dogs: Diagnostic and Prognostic Values.
- Authors
Cavalera, Maria Alfonsa; Zatelli, Andrea; Donghia, Rossella; Mendoza-Roldan, Jairo Alfonso; Gernone, Floriana; Otranto, Domenico; Iatta, Roberta
- Abstract
Simple Summary: This 10-month-long study describes how conjunctival swab (CS) real time-PCR (qPCR) failed to be a useful diagnostic and prognostic test for canine leishmaniosis (CanL). From the beginning of the study (October 2020), a limited number of Leishmania infantum seropositive dogs remained CS qPCR positive in August 2021, and none of them developed an active CanL. Therefore, the detection of L. infantum kDNA by qPCR, even highly sensitive, may be considered "a random" if not accompanied by a significant clinical score for CanL and/or other direct diagnostic tests positivity. Hence, in seropositive dogs with CS qPCR positivity, sampling time and season variability of results should be considered. In this scenario, testing other significant biological samples (e.g., lymph node, bone marrow, and spleen), although invasive, is strongly advised. Conjunctival swabs (CS) are the most promising non-invasive samples for the diagnosis and the regular screening of Leishmania infantum infection in dogs although knowledge on their diagnostic performance is still inconclusive. This study evaluates CS real time-PCR (qPCR) analysis for the diagnosis of canine leishmaniosis (CanL) and its prognostic value in seropositive dogs from an endemic area. In October 2020 (T0), 26 dogs were enrolled, divided in two groups according to anti-L. infantum antibody titres (n = 13, group low titre (LT) and n = 13, group high titre (HT)), and followed-up in August 2021. At both timepoints, animals underwent clinical examination, complete blood count and biochemical analyses, and serological (indirect fluorescent antibody test) and molecular (CS and peripheral blood qPCR) testing. At T0, 10 out of 26 enrolled dogs were positive at CS qPCR, with the number of positive animals significantly higher in group HT than in LT. After 10 months, only 5 out of 21 dogs that completed the trial still tested CS qPCR positive, and none of them developed an active CanL based on clinical score and antibody titre. None of the dogs required any leishmanicidal and/or leishmaniostatic treatments. This prospective study showed unsatisfying diagnostic and prognostic performances of CS qPCR analysis in L. infantum seropositive asymptomatic dogs from an endemic area.
- Subjects
FLUORESCENT antibody technique; LEISHMANIA infantum; PROGNOSIS; DOGS; BLOOD cell count; ANTIBODY titer
- Publication
Biology (2079-7737), 2022, Vol 11, Issue 2, p184
- ISSN
2079-7737
- Publication type
Article
- DOI
10.3390/biology11020184